Spain In-Vitro Diagnostic Market is predicted to reach USD 1.56 Billion by 2030

According to the study by Next Move Strategy Consulting, the Spain In-Vitro Diagnostics Market size is predicted to reach USD 1.56 billion, at a CAGR of 3.7% by 2030.

Request a FREE Sample: https://www.nextmsc.com/spain-in-vitro-diagnostic-market/request-sample

The increasing aging demographic in Spain significantly drives the expansion of the in-vitro diagnostics market. As per OECD, Spain's population is aging quickly, with an expected increase in the proportion of people aged 65 and above compared to those aged 20-64.

The widespread occurrence of cardiovascular diseases is further fuelling the growth of the in-vitro diagnostics market in Spain.

The promising players operating in the Spain in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.